304 related articles for article (PubMed ID: 28464343)
21. An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial 'acid pocket' in symptomatic GERD patients.
Kwiatek MA; Roman S; Fareeduddin A; Pandolfino JE; Kahrilas PJ
Aliment Pharmacol Ther; 2011 Jul; 34(1):59-66. PubMed ID: 21535446
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic value of alginate test in gastroesophageal reflux disease].
Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
[TBL] [Abstract][Full Text] [Related]
23. [Gastroesophageal reflux disease during pregnancy].
Elokhina TB; Tiutiunnik VL
Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
[No Abstract] [Full Text] [Related]
24. A comparison of the efficacy of the alginate preparation, Gaviscon Advance, with placebo in the treatment of gastro-oesophageal reflux disease.
Chatfield S
Curr Med Res Opin; 1999; 15(3):152-9. PubMed ID: 10621921
[TBL] [Abstract][Full Text] [Related]
25. [Alginate improves symptom control].
Siegmund-Schultze N
MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
[No Abstract] [Full Text] [Related]
26. Effect of alginate in patients with GERD hiatal hernia matters.
Vardar R; Keskin M; Valitova E; Bayrakci B; Yildirim E; Bor S
Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859383
[TBL] [Abstract][Full Text] [Related]
27. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
Tytgat GN; Simoneau G
Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
[TBL] [Abstract][Full Text] [Related]
28. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
[No Abstract] [Full Text] [Related]
29. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
[TBL] [Abstract][Full Text] [Related]
30. [The experience of usage of alginate contain medication in complex therapy at children with GERD disease].
Shcherbakov PL; Lobanov IuF; Fugol DS; Shilova AV
Eksp Klin Gastroenterol; 2009; (5):81-4. PubMed ID: 20201310
[TBL] [Abstract][Full Text] [Related]
31. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.
Rohof WO; Bennink RJ; Smout AJ; Thomas E; Boeckxstaens GE
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1585-91; quiz e90. PubMed ID: 23669304
[TBL] [Abstract][Full Text] [Related]
32. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
Buts JP; Barudi C; Otte JB
Eur J Pediatr; 1987 Mar; 146(2):156-8. PubMed ID: 3032640
[TBL] [Abstract][Full Text] [Related]
33. [Heartburn and regurgitation in pregnancy. Efficacy and innocuousness of treatment with Gaviscon suspension].
Uzan M; Uzan S; Sureau C; Richard-Berthe C
Rev Fr Gynecol Obstet; 1988; 83(7-9):569-72. PubMed ID: 2848305
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic response to GERDOFF® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study.
Boarino V; Raguzzi I; Marocchi M; Merighi A
Turk J Gastroenterol; 2020 Jun; 31(6):466-473. PubMed ID: 32721918
[TBL] [Abstract][Full Text] [Related]
35. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
Kim SE; Park MI
Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
[No Abstract] [Full Text] [Related]
36. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
Chevrel B
J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
[TBL] [Abstract][Full Text] [Related]
37. In-vivo anti-reflux and raft properties of alginates.
Lambert JR; Korman MG; Nicholson L; Chan JG
Aliment Pharmacol Ther; 1990 Dec; 4(6):615-22. PubMed ID: 2129648
[TBL] [Abstract][Full Text] [Related]
38. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
Hutt HJ; Tauber O; Flach D
Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
[TBL] [Abstract][Full Text] [Related]
39. Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pH.
Del Buono R; Wenzl TG; Ball G; Keady S; Thomson M
Arch Dis Child; 2005 May; 90(5):460-3. PubMed ID: 15851425
[TBL] [Abstract][Full Text] [Related]
40. [Alginate on demand as add-on for patients with gastro-oesophageal reflux disease and insufficient PPI effect].
Müller M; Labenz G; Borkenstein DP; Labenz J;
Dtsch Med Wochenschr; 2019 Feb; 144(4):e30-e35. PubMed ID: 30466131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
